The results have been published online in the peer-reviewed journal
Brain Pathology. The findings demonstrate microRNAs' significant
potential to act as effective biomarkers that may be applied in a
diagnostic test designed to identify primary tumors in patients with
Conferences and Events
Rosetta Genomics presented at the following conferences and events:
- Collins Stewart Fourth Annual Growth Conference, July 2008,
- American Society of Clinical Oncology (ASCO) Annual Meeting,
June 2008, Chicago, Illinois
- AACR International Conference on Molecular Diagnostics in
Cancer Therapeutic Development. September 22-25, Philadelphia,
- Maxim Group Growth Conference, October 7th, New York.
Conference Call Information
Rosetta Genomics will host a conference call at 08:30 a.m. ET today to discuss second-quarter activities and recent corporate developments. To access the live conference call, U.S. and Canadian participants may dial 1-866-966-5335; international participants may dial +44-20-3023-4460. To access the 24-hour audio replay, U.S. and Canadian participants may dial 1-866-583-1035; international participants may dial 44-20-8196-1998. The access code for the replay is 181543#. The replay will be available until August 26, 2008.
A live audio webcast of the call will also be available on the "Investors" section of the company's website http://www.rosettagenomics.com. An archived webcast will be available on the Company's website approximately two hours after the event, and will be archived for 30 days thereafter.
MicroRNAs (miRNAs) are recently discovered, naturally occurring, small
RNAs that act as master regulators and have the potenti
|SOURCE Rosetta Genomics Ltd|
Copyright©2008 PR Newswire.
All rights reserved